metformin
-
healthACTIV-6 Trial: Metformin Reduces Clinician-Diagnosed Long COVID Risk
The ACTIV-6 randomized trial reveals metformin lowers clinician-diagnosed long COVID by 50% in immune outpatients, despite missing primary endpoints for patient-reported symptom prevention at six months.
-
healthCommon Diabetes Drugs Show Promise Against Antibiotic-Resistant E. Coli
New research finds empagliflozin and metformin can inhibit urinary E. coli biofilms and virulence genes, suggesting drug repurposing potential.
-
healthDiabetes Drug Metformin Linked to Exceptional Longevity in Older Women
Study finds metformin may help postmenopausal women live to 90, showing a 30% lower mortality risk compared to other diabetes drugs.
-
healthMetformin Shows Potential in Preventing Esophageal Cancer
A Nordic study suggests the common diabetes drug Metformin may significantly lower the risk of esophageal squamous cell carcinoma, offering new avenues for prevention and treatment.
-
healthDiabetes Drug Metformin Acts Directly in the Brain, Study Finds
After 60 years of use, metformin’s brain-based mechanism is uncovered-opening doors to new diabetes and anti-aging therapies.
-
healthMetformin Linked to 37% Lower Risk of Macular Degeneration in Diabetics
A 2026 study found metformin significantly reduces intermediate AMD risk in Type 2 diabetes patients, suggesting potential beyond glycemic control.